Related Experiment Videos
Future of melatonin as a therapeutic agent
Michal Karasek1, Russel J Reiter, Daniel P Cardinali
1Clinic of Endocrinology, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland. karasek@csk.am.lodz.pl
Neuro Endocrinology Letters
|May 23, 2002
Summary
This report summarizes the International Symposium on Melatonin, highlighting its established use for sleep disorders and circadian rhythm issues. It also explores potential therapeutic applications in cancer and free radical-related diseases.
Area of Science:
- Endocrinology
- Pharmacology
- Sleep Medicine
Background:
- Melatonin is a hormone primarily known for regulating sleep-wake cycles.
- Established indications for melatonin treatment include sleep disorders and circadian rhythm disturbances.
Purpose of the Study:
- To summarize the findings of the International Symposium on Melatonin: Clinical Significance and Therapeutic Applications.
- To explore established and potential therapeutic uses of melatonin.
- To discuss safety, dosage, side effects, and contraindications of melatonin therapy.
Main Methods:
- The content is based on a round table conference summarizing the International Symposium on Melatonin.
- Discussion and presentation of scientific data and expert opinions.
Main Results:
- Melatonin is widely accepted for treating sleep disorders and circadian rhythm disturbances.
- Emerging evidence suggests potential co-treatment roles for melatonin in cancer patients and free radical-related diseases.
Conclusions:
- Melatonin has established clinical significance in sleep and circadian rhythm regulation.
- Further research into melatonin's therapeutic potential for cancer and oxidative stress-related conditions is warranted.
- Comprehensive understanding of melatonin's safety profile, optimal dosage, and contraindications is crucial for clinical application.